Sincere Co., Ltd. (Japan)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3376500009
JPY
521.00
5 (0.97%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Create Medic Co., Ltd.
Kawamoto Corp.
Sincere Co., Ltd. (Japan)
Kowa Co. Ltd. (Osaka)
JMS Co., Ltd.
Techno Medica Co., Ltd.
Precision System Science Co., Ltd.
Immuno-Biological Laboratories Co., Ltd.
3-D Matrix Ltd.
Koken Ltd.
Shigematsu Works Co., Ltd.
Why is Sincere Co., Ltd. (Japan) ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 45.32
2
Healthy long term growth as Operating profit has grown by an annual rate 29.93%
3
Negative results in Jun 25
  • INTEREST COVERAGE RATIO(Q) Lowest at 2,385.14
  • DEBT-EQUITY RATIO (HY) Highest at 10.49 %
  • INTEREST(Q) Highest at JPY 6.02 MM
4
With ROE of 13.85%, it has a very attractive valuation with a 1.62 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -1.14%, its profits have risen by 63.6% ; the PEG ratio of the company is 0.2
5
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -1.14% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Sincere Co., Ltd. (Japan) should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sincere Co., Ltd. (Japan) for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sincere Co., Ltd. (Japan)
-1.14%
0.32
43.56%
Japan Nikkei 225
28.54%
1.11
25.75%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.03%
EBIT Growth (5y)
29.93%
EBIT to Interest (avg)
45.32
Debt to EBITDA (avg)
0.60
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
1.40
Tax Ratio
32.77%
Dividend Payout Ratio
40.22%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.92%
ROE (avg)
8.80%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.62
EV to EBIT
8.12
EV to EBITDA
6.96
EV to Capital Employed
1.53
EV to Sales
0.70
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
18.86%
ROE (Latest)
13.85%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET PROFIT(HY)

At JPY 178.16 MM has Grown at 91.97%

ROCE(HY)

Highest at 14.07%

INVENTORY TURNOVER RATIO(HY)

Highest at 4.26%

NET SALES(Q)

Highest at JPY 1,991.44 MM

-13What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 2,385.14

DEBT-EQUITY RATIO (HY)

Highest at 10.49 %

INTEREST(Q)

Highest at JPY 6.02 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 7.21 %

Here's what is working for Sincere Co., Ltd. (Japan)
Net Profit
At JPY 178.16 MM has Grown at 91.97%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (JPY MM)

Net Sales
Highest at JPY 1,991.44 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Net Sales
At JPY 1,991.44 MM has Grown at 21.13%
over average net sales of the previous four periods of JPY 1,644.03 MM
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Inventory Turnover Ratio
Highest at 4.26%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Sincere Co., Ltd. (Japan)
Interest Coverage Ratio
Lowest at 2,385.14
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest
Highest at JPY 6.02 MM
in the last five periods and Increased by 9.96% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Operating Profit Margin
Lowest at 7.21 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio
Highest at 10.49 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio